[1] D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next generation, Cell 144 (2011) 646–674, https://doi.org/10.1016/j.cell.2011.02.013.
[2] S.K. Biswas, A. Mantovani, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nat. Immunol. 11 (2010) 889–896, https://doi.org/ 10.1038/ni.1937.
[3] M. Takeya, Y. Komohara, Role of tumor-associated macrophages in human malignancies: friend or foe? Pathol. Int. (2016) 491–505, https://doi.org/10.1111/ pin.12440.
[4] D. Ohlund, E. Elyada, D. Tuveson, Fibroblast heterogeneity in the cancer wound, J. Exp. Med. 211 (2014) 1503–1523, https://doi.org/10.1084/jem.20140692.
[5] R. Kalluri, The biology and function of fibroblasts in cancer, Nat. Rev. Cancer 16 (2016) 582–598, https://doi.org/10.1038/nrc.2016.73.
[6] B. Thibault, M. Castells, J.P. Delord, B. Couderc, Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition, Cancer Metastasis Rev. 33 (2014) 17–39, https://doi.org/10.1007/ s10555-013-9456-2.
[7] J. Cai, H. Tang, L. Xu, X. Wang, C. Yang, S. Ruan, J. Guo, S. Hu, Z. Wang, Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness, Carcinogenesis 33 (2012) 20–29, https://doi.org/ 10.1093/carcin/bgr230.
[8] C.I. Ripamonti, A.M. Easson, H. Gerdes, Management of malignant bowel obstruction, Eur. J. Cancer 44 (2008) 1105–1115, https://doi.org/10.1016/j. ejca.2008.02.028.
[9] P. Chiarugi, Cancer-associated fibroblasts and macrophages friendly conspirators for malignancy, OncoImmunology 2 (2013) 1–3, https://doi.org/10.4161/ onci.25563.
[10] Y. Nie, J. Chen, D. Huang, Y. Yao, J. Chen, L. Ding, J. Zeng, S. Su, X. Chao, F. Su, H. Yao, H. Hu, E. Song, Tumor-associated macrophages promote malignant progression of breast phyllodes tumors by inducing myofibroblast differentiation, Cancer Res. 77 (2017) 3605–3618, https://doi.org/10.1158/0008-5472.CAN-16-2709.
[11] D.J. Nikolic-Paterson, S. Wang, H.Y. Lan, Macrophages promote renal fibrosis through direct and indirect mechanisms, Kidney Int. Suppl. 4 (2014) 34–38, https://doi.org/10.1038/kisup.2014.7.
[12] R.G. Gourdie, S. Dimmeler, P. Kohl, Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease, Nat. Rev. Drug Discov. 15 (2016) 620–638, https://doi.org/10.1038/nrd.2016.89.
[13] M. Ogawa, A.C. LaRue, C.J. Drake, Hematopoietic origin of fibroblasts/ myofibroblasts: its pathophysiologic implications, Blood 108 (2006) 2893–2896, https://doi.org/10.1182/blood-2006-04-016600.
[14] H. Li, R. Durbin, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics 25 (2009) 1754–1760, https://doi.org/10.1093/ bioinformatics/btp324.
[15] M.A. Depristo, E. Banks, R. Poplin, K.V. Garimella, J.R. Maguire, C. Hartl, A. A. Philippakis, G. Del Angel, M.A. Rivas, M. Hanna, A. McKenna, T.J. Fennell, A. M. Kernytsky, A.Y. Sivachenko, K. Cibulskis, S.B. Gabriel, D. Altshuler, M.J. Daly, A framework for variation discovery and genotyping using next-generation DNA sequencing data, Nat. Genet. 43 (2011) 491–501, https://doi.org/10.1038/ng.806.
[16] D.C. Koboldt, Q. Zhang, D.E. Larson, D. Shen, M.D. Mclellan, L. Lin, C. a Miller, E. R. Mardis, L. Ding, R.K. Wilson, VarScan 2 : somatic mutation and copy number alteration discovery in cancer by exome sequencing VarScan 2 : somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res. 22 (2012) 568–576, https://doi.org/10.1101/gr.129684.111.
[17] J.T. Robinson, H. Thorvaldsdo´ttir, W. Winckler, M. Guttman, E.S. Lander, G. Getz, J.P. Mesirov, Integrative genomics viewer, Nat. Biotechnol. 29 (2011) 24–26, https://doi.org/10.1038/nbt.1754.
[18] T. Yamauchi, K. Takenaka, S. Urata, T. Shima, Y. Kikushige, T. Tokuyama, C. Iwamoto, M. Nishihara, H. Iwasaki, T. Miyamoto, N. Honma, M. Nakao, T. Matozaki, K. Akashi, Polymorphic Sirpa is the genetic determinant for NOD- based mouse lines to achieve efficient human cell engraftment, Blood 121 (2013) 1316–1325, https://doi.org/10.1182/blood-2012-06-440354.
[19] D. Pilling, T. Fan, D. Huang, B. Kaul, R.H. Gomer, Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts, PLoS One 4 (2009), e7475, https://doi.org/10.1371/journal. pone.0007475.
[20] R. Kalluri, M. Zeisberg, Fibroblasts in cancer, Nat. Rev. Cancer 6 (2006) 392–401, https://doi.org/10.1038/nrc1877.
[21] H. Li, E.T. Courtois, D. Sengupta, Y. Tan, K.H. Chen, J.J.L. Goh, S.L. Kong, C. Chua,L.K. Hon, W.S. Tan, M. Wong, P.J. Choi, L.J.K. Wee, A.M. Hillmer, I.B. Tan, P. Robson, S. Prabhakar, Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors, Nat. Genet. 49 (2017) 708–718, https://doi.org/10.1038/ng.3818.
[22] M. Beyer, M.R. Mallmann, J. Xue, A. Staratschek-jox, D. Vorholt, W. Krebs, D. Sommer, J. Sander, C. Mertens, A. Nino-castro, S. V Schmidt, J.L. Schultze, High-Resolution Transcriptome of Human Macrophages, 7, 2012, https://doi.org/ 10.1371/journal.pone.0045466.
[23] M. Heusinkveld, S.H. van der Burg, Identification and manipulation of tumor associated macrophages in human cancers, J. Transl. Med. 9 (2011) 216, https:// doi.org/10.1186/1479-5876-9-216.
[24] S. Tripathi, M.O. Pohl, Y. Zhou, A. Rodriguez-Frandsen, G. Wang, D.A. Stein, H. M. Moulton, P. Dejesus, J. Che, L.C.F. Mulder, E. Y´angüez, D. Andenmatten, L. Pache, B. Manicassamy, R.A. Albrecht, M.G. Gonzalez, Q. Nguyen, A. Brass, S. Elledge, M. White, S. Shapira, N. Hacohen, A. Karlas, T.F. Meyer, M. Shales, A. Gatorano, J.R. Johnson, G. Jang, T. Johnson, E. Verschueren, D. Sanders, N. Krogan, M. Shaw, R. Ko¨nig, S. Stertz, A. García-Sastre, S.K. Chanda, Meta- and orthogonal integration of influenza “oMICs” data defines a role for UBR4 in virus budding, Cell Host Microbe 18 (2015) 723–735, https://doi.org/10.1016/j. chom.2015.11.002.
[25] R. Rawson, T. Yang, R.O. Newbury, M. Aquino, A. Doshi, B. Bell, D.H. Broide, R. Dohil, R. Kurten, S.S. Aceves, TGF-β1–induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis, J. Allergy Clin. Immunol. 138 (2016) 791–800, https://doi.org/10.1016/j.jaci.2016.02.028, e4.
[26] L.J. Schedlich, V.M. Yenson, R.C. Baxter, TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells, Mol. Cell. Endocrinol. 377 (2013) 56–64, https://doi.org/10.1016/j.mce.2013.06.033.
[27] S. Akiyoshi, M. Ishii, N. Nemoto, M. Kawabata, H. Aburatani, K. Miyazono, Targets of transcriptional regulation by transforming growth factor-β: expression profile analysis using oligonucleotide arrays, Japanese, J. Cancer Res. 92 (2001) 257–268, https://doi.org/10.1111/j.1349-7006.2001.tb01090.x.
[28] S. Carbon, A. Ireland, C.J. Mungall, S. Shu, B. Marshall, S. Lewis, J. Lomax, C. Mungall, B. Hitz, R. Balakrishnan, M. Dolan, V. Wood, E. Hong, P. Gaudet, AmiGO: online access to ontology and annotation data, Bioinformatics 25 (2009) 288–289, https://doi.org/10.1093/bioinformatics/btn615.
[29] S. Carbon, H. Dietze, S.E. Lewis, C.J. Mungall, M.C. Munoz-Torres, S. Basu, R. L. Chisholm, R.J. Dodson, P. Fey, P.D. Thomas, H. Mi, A. Muruganujan, X. Huang, S. Poudel, J.C. Hu, S.A. Aleksander, B.K. McIntosh, D.P. Renfro, D.A. Siegele, G. Antonazzo, H. Attrill, N.H. Brown, S.J. Marygold, P. Mc-Quilton, L. Ponting, G. H. Millburn, A.J. Rey, R. Stefancsik, S. Tweedie, K. Falls, A.J. Schroeder, M. Courtot, D. Osumi-Sutherland, H. Parkinson, P. Roncaglia, R.C. Lovering, R. E. Foulger, R.P. Huntley, P. Denny, N.H. Campbell, B. Kramarz, S. Patel, J. L. Buxton, Z. Umrao, A.T. Deng, H. Alrohaif, K. Mitchell, F. Ratnaraj, W. Omer, M. Rodríguez-Lo´pez, M.C. Chibucos, M. Giglio, S. Nadendla, M.J. Duesbury, M. Koch, B.H.M. Meldal, A. Melidoni, P. Porras, S. Orchard, A. Shrivastava, H. Y. Chang, R.D. Finn, M. Fraser, A.L. Mitchell, G. Nuka, S. Potter, N.D. Rawlings, L. Richardson, A. Sangrador-Vegas, S.Y. Young, J.A. Blake, K.R. Christie, M. E. Dolan, H.J. Drabkin, D.P. Hill, L. Ni, D. Sitnikov, M.A. Harris, J. Hayles, S. G. Oliver, K. Rutherford, V. Wood, J. Bahler, A. Lock, J. De Pons, M. Dwinell, M. Shimoyama, S. Laulederkind, G.T. Hayman, M. Tutaj, S.J. Wang, P. D’Eustachio, L. Matthews, J.P. Balhoff, R. Balakrishnan, G. Binkley, J.M. Cherry, M.C. Costanzo, S.R. Engel, S.R. Miyasato, R.S. Nash, M. Simison, M.S. Skrzypek, S. Weng, E.D. Wong, M. Feuermann, P. Gaudet, T.Z. Berardini, D. Li, B. Muller, L. Reiser, E. Huala, J. Argasinska, C. Arighi, A. Auchincloss, K. Axelsen, G. Argoud- Puy, A. Bateman, B. Bely, M.C. Blatter, C. Bonilla, L. Bougueleret, E. Boutet, L. Breuza, A. Bridge, R. Britto, H. Hye- A-Bye, C. Casals, E. Cibrian-Uhalte, E. Coudert, I. Cusin, P. Duek-Roggli, A. Estreicher, L. Famiglietti, P. Gane, P. Garmiri, G. Georghiou, A. Gos, N. Gruaz-Gumowski, E. Hatton-Ellis, U. Hinz, A. Holmes, C. Hulo, F. Jungo, G. Keller, K. Laiho, P. Lemercier, D. Lieberherr, A. Mac- Dougall, M. Magrane, M.J. Martin, P. Masson, D.A. Natale, C. O’Donovan, I. Pedruzzi, K. Pichler, D. Poggioli, S. Poux, C. Rivoire, B. Roechert, T. Sawford, M. Schneider, E. Speretta, A. Shypitsyna, A. Stutz, S. Sundaram, M. Tognolli, C. Wu, I. Xenarios, L.S. Yeh, J. Chan, S. Gao, K. Howe, R. Kishore, R. Lee, Y. Li, J. Lomax, H.M. Muller, D. Raciti, K. Van Auken, M. Berriman, L. Stein, Kersey Paul, P.W. Sternberg, D. Howe, M. Westerfield, Expansion of the gene ontology knowledgebase and resources: the gene ontology consortium, Nucleic Acids Res. 45 (2017) D331–D338, https://doi.org/10.1093/nar/gkw1108.
[30] M. Ashburner, C.A. Ball, J.A. Blake, D. Botstein, H. Butler, J.M. Cherry, A.P. Davis, K. Dolinski, S.S. Dwight, J.T. Eppig, M.A. Harris, D.P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J.C. Matese, J.E. Richardson, M. Ringwald, G.M. Rubin, G. Sherlock, Gene ontology: tool for the unification of biology, Nat. Genet. 25 (2000) 25–29, https://doi.org/10.1038/75556.
[31] S. Iwano, M. Sugiyama, H. Hama, A. Watakabe, N. Hasegawa, T. Kuchimaru, K. Z. Tanaka, M. Takahashi, Y. Ishida, J. Hata, S. Shimozono, K. Namiki, T. Fukano, M. Kiyama, H. Okano, S. Kizaka-Kondoh, T.J. McHugh, T. Yamamori, H. Hioki, S. Maki, A. Miyawaki, Single-cell bioluminescence imaging of deep tissue in freely moving animals, Science 80 (359) (2018) 935–939, https://doi.org/10.1126/ science.aaq1067.
[32] M. Nakano, M. Ito, R. Tanaka, H. Ariyama, K. Mitsugi, A. Makiyama, K. Uchino, T. Esaki, N. Tsuruta, F. Hanamura, K. Yamaguchi, Y. Okumura, K. Sagara, K. Takayoshi, K. Nio, K. Tsuchihashi, S. Tamura, H. Shimokawa, S. Arita, K. Miyawaki, H. Kusaba, K. Akashi, E. Baba, Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancer, Cancer Sci. 109 (2018) 3461–3470, https://doi.org/10.1111/cas.13777.
[33] H. Zhou, M. Sivasankar, D.H. Kraus, V.C. Sandulache, M. Amin, R.C. Branski, Glucocorticoids regulate extracellular matrix metabolism in human vocal fold fibroblasts, Laryngoscope 121 (2011) 1915–1919, https://doi.org/10.1002/ lary.21920.
[34] S. Jaiswal, P. Fontanillas, J. Flannick, A. Manning, P. V Grauman, B.G. Mar, R. C. Lindsley, C.H. Mermel, N. Burtt, A. Chavez, J.M. Higgins, V. Moltchanov, F. C. Kuo, M.J. Kluk, B. Henderson, L. Kinnunen, H.A. Koistinen, C. Ladenvall, G. Getz, A. Correa, B.F. Banahan, S. Gabriel, S. Kathiresan, H.M. Stringham, M. I. McCarthy, M. Boehnke, J. Tuomilehto, C. Haiman, L. Groop, G. Atzmon, J. G. Wilson, D. Neuberg, D. Altshuler, B.L. Ebert, Age-related clonal hematopoiesis associated with adverse outcomes, N. Engl. J. Med. 371 (2014) 2488–2498, https://doi.org/10.1056/NEJMoa1408617.
[35] S. Jaiswal, P. Natarajan, A.J. Silver, C.J. Gibson, A.G. Bick, E. Shvartz, M. McConkey, N. Gupta, S. Gabriel, D. Ardissino, U. Baber, R. Mehran, V. Fuster, J. Danesh, P. Frossard, D. Saleheen, O. Melander, G.K. Sukhova, D. Neuberg, P. Libby, S. Kathiresan, B.L. Ebert, Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease, N. Engl. J. Med. 377 (2017) 111–121, https://doi.org/ 10.1056/NEJMoa1701719.
[36] H.Y. Chang, J.-T.J. Chi, S. Dudoit, C. Bondre, M. van de Rijn, D. Botstein, P. O. Brown, M. Van De Rijn, D. Botstein, P.O. Brown, Diversity, topographic differentiation, and positional memory in human fibroblasts, Proc. Natl. Acad. Sci. Unit. States Am. 99 (2002) 12877–12882, https://doi.org/10.1073/ pnas.162488599.
[37] J.H. Lee, T. Tammela, M. Hofree, J. Choi, N.D. Marjanovic, S. Han, D. Canner, K. Wu, M. Paschini, D.H. Bhang, T. Jacks, A. Regev, C.F. Kim, Anatomically and functionally distinct lung mesenchymal populations marked by Lgr5 and Lgr6, Cell 170 (2017) 1149–1163, https://doi.org/10.1016/j.cell.2017.07.028, e12.
[38] T.T. Braga, J.S.H. Agudelo, N.O.S. Camara, Macrophages during the fibrotic process: M2 as friend and foe, Front. Immunol. 6 (2015) 1–8, https://doi.org/ 10.3389/fimmu.2015.00602.
[39] H. Mo¨llmann, H.M. Nef, S. Kostin, C. von Kalle, I. Pilz, M. Weber, J. Schaper, C. W. Hamm, A. Elsa¨sser, Bone marrow-derived cells contribute to infarct remodelling, Cardiovasc. Res. 71 (2006) 661–671, https://doi.org/10.1016/j. cardiores.2006.06.013.
[40] S.J. Forbes, F.P. Russo, V. Rey, P. Burra, M. Rugge, N.A. Wright, M.R. Alison, A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis, Gastroenterology 126 (2004) 955–963, https://doi.org/10.1053/j. gastro.2004.02.025.
[41] M. Quante, S.P. Tu, H. Tomita, T. Gonda, S.S.W. Wang, S. Takashi, G.H. Baik, W. Shibata, B. Diprete, K.S. Betz, R. Friedman, A. Varro, B. Tycko, T.C. Wang, Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth, Cancer Cell 19 (2011) 257–272, https://doi.org/10.1016/ j.ccr.2011.01.020.
[42] A. Huijbers, R.A.E.M. Tollenaar, G.W. V Pelt, E.C.M. Zeestraten, S. Dutton, C. C. McConkey, E. Domingo, V.T.H.B.M. Smit, R. Midgley, B.F. Warren, E. C. Johnstone, D.J. Kerr, W.E. Mesker, The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the victor trial, Ann. Oncol. 24 (2013) 179–185, https://doi.org/10.1093/annonc/mds246.
[43] F. De Sousa E Melo, X. Wang, M. Jansen, E. Fessler, A. Trinh, L.P.M.H. de Rooij, J. H. de Jong, O.J. de Boer, R. van Leersum, M.F. Bijlsma, H. Rodermond, M. van der Heijden, C.J.M. van Noesel, J.B. Tuynman, E. Dekker, F. Markowetz, J.P. Medema, L. Vermeulen, Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions, Nat. Med. 19 (2013) 614–618, https://doi.org/10.1038/nm.3174.
[44] A. Sadanandam, C. a Lyssiotis, K. Homicsko, E. a Collisson, W.J. Gibb, S. Wullschleger, L.C.G. Ostos, W. a Lannon, C. Grotzinger, M. Del Rio, B. Lhermitte, A.B. Olshen, B. Wiedenmann, L.C. Cantley, J.W. Gray, D. Hanahan, A colorectal cancer classification system that associates cellular phenotype and responses to therapy, Nat. Med. 19 (2013) 619–625, https://doi.org/10.1038/nm.3175.
[45] L. Marisa, A. de Reyni`es, A. Duval, J. Selves, M.P. Gaub, L. Vescovo, M.C. Etienne- Grimaldi, R. Schiappa, D. Guenot, M. Ayadi, S. Kirzin, M. Chazal, J.F. Fl´ejou, D. Benchimol, A. Berger, A. Lagarde, E. Pencreach, F. Piard, D. Elias, Y. Parc, S. Olschwang, G. Milano, P. Laurent-Puig, V. Boige, Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value, PLoS Med. 10 (2013), https://doi.org/10.1371/journal. pmed.1001453.
[46] A. Sadanandam, X. Wang, F. De Sousa E Melo, J.W. Gray, L. Vermeulen, D. Hanahan, J.P. Medema, Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications, Cell Cycle 13 (2014) 353–357, https://doi.org/10.4161/cc.27769.
[47] C. Isella, A. Terrasi, S.E. Bellomo, C. Petti, G. Galatola, A. Muratore, A. Mellano, R. Senetta, A. Cassenti, C. Sonetto, G. Inghirami, L. Trusolino, Z. Fekete, M. De Ridder, P. Cassoni, G. Storme, A. Bertotti, E. Medico, Stromal contribution to the colorectal cancer transcriptome, Nat. Genet. 47 (2015) 312–319, https://doi.org/ 10.1038/ng.3224.
[48] S. Müller, G. Kohanbash, S.J. Liu, B. Alvarado, D. Carrera, A. Bhaduri, P. B. Watchmaker, G. Yagnik, E. Di Lullo, M. Malatesta, N.M. Amankulor, A. R. Kriegstein, D.A. Lim, M. Aghi, H. Okada, A. Diaz, Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment, Genome Biol. 18 (2017) 234, https://doi.org/10.1186/s13059-017-1362-4.
[49] J.J. Fuster, S. MacLauchlan, M.A. Zuriaga, M.N. Polackal, A.C. Ostriker, R. Chakraborty, C. Wu, S. Sano, S. Muralidharan, C. Rius, J. Vuong, S. Jacob, V. Muralidhar, A.A.B. Robertson, M.A. Cooper, V. Andr´es, K.K. Hirschi, K. A. Martin, K. Walsh, Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice, Science 355 (2017) 842–847, https://doi.org/10.1126/science.aag1381.
[50] L. Helming, S. Gordon, Molecular mediators of macrophage fusion, Trends Cell Biol. 19 (2009) 514–522, https://doi.org/10.1016/j.tcb.2009.07.005.
[51] V.T. Fabris, A. Sahores, S.I. Vanzulli, L. Colombo, A.A. Molinolo, C. Lanari, C. A. Lamb, Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth, BMC Cancer 10 (2010), https://doi.org/ 10.1186/1471-2407-10-293.
[52] J. Linxweiler, T. Hajili, C. Ko¨rbel, C. Berchem, P. Zeuschner, A. Müller, M. Sto¨ckle, M.D. Menger, K. Junker, M. Saar, Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model, Sci. Rep. 10 (2020) 1–13, https://doi.org/10.1038/s41598-020-69424-x.
[53] C.B. Nanthakumar, R.J.D. Hatley, S. Lemma, J. Gauldie, R.P. Marshall, S.J. F. Macdonald, Dissecting fibrosis: therapeutic insights from the small-molecule toolbox, Nat. Rev. Drug Discov. 14 (2015) 693–720, https://doi.org/10.1038/ nrd4592.
[54] R.J. Akhurst, A. Hata, Targeting the TGFβ signalling pathway in disease, Nat. Rev. Drug Discov. 11 (2012) 790–811, https://doi.org/10.1038/nrd3810.
[55] S.A. Mani, W. Guo, M.-J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, R.A. Weinberg, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell 133 (2008) 704–715, https://doi.org/10.1016/j. cell.2008.03.027.
[56] J. Rodon, M.A. Carducci, J.M. Sepulveda-S´anchez, A. Azaro, E. Calvo, J. Seoane, I. Bran˜a, E. Sicart, I. Gueorguieva, A.L. Cleverly, N.S. Pillay, D. Desaiah, S. T. Estrem, L. Paz-Ares, M. Holdhoff, J. Blakeley, M.M. Lahn, J. Baselga, First-in- human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma, Clin. Cancer Res. 21 (2015) 553–560, https://doi.org/10.1158/1078-0432.CCR-14-1380.
[57] G. Giaccone, L.A. Bazhenova, J. Nemunaitis, M. Tan, E. Juh´asz, R. Ramlau, M. M. van den Heuvel, R. Lal, G.H. Kloecker, K.D. Eaton, Q. Chu, D.J. Dunlop, M. Jain, E.B. Garon, C.S. Davis, E. Carrier, S.C. Moses, D.L. Shawler, H. Fakhrai, A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer, Eur. J. Cancer 51 (2015) 2321–2329, https://doi.org/10.1016/j.ejca.2015.07.035.
論文の公開元へ
